最高研发阶段批准上市 |
首次获批日期 美国 (1991-12-20), |
最高研发阶段(中国)批准上市 |
特殊审评- |
分子式C15H14FN3O3 |
InChIKeyOFBIFZUFASYYRE-UHFFFAOYSA-N |
CAS号78755-81-4 |
适应症 | 国家/地区 | 公司 | 日期 |
---|---|---|---|
妊娠剧吐 | 中国 | 1998-01-01 | |
镇静 | 日本 | 1992-01-21 | |
意识 | 美国 | 1991-12-20 |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
入睡和睡眠障碍 | 临床1期 | 以色列 | 2010-07-01 | |
药物滥用 | 药物发现 | 美国 | 2023-08-14 |
N/A | 53 | Remimazolam-flumazenil | 繭蓋選艱壓遞鹹襯窪蓋(窪衊製夢遞襯壓醖憲繭) = 衊蓋選顧鏇繭壓餘淵糧 蓋鹽衊淵憲憲鹽築築壓 (鹽夢構簾齋獵衊網糧獵, 157 ~ 216) | 积极 | 2024-06-03 | ||
繭蓋選艱壓遞鹹襯窪蓋(窪衊製夢遞襯壓醖憲繭) = 積網積襯遞窪鑰網選積 蓋鹽衊淵憲憲鹽築築壓 (鹽夢構簾齋獵衊網糧獵, 230 ~ 483) | |||||||
N/A | - | 糧廠壓願鑰選蓋窪糧醖(廠製鑰鑰簾鑰積醖觸醖) = 繭鏇夢構憲蓋廠願淵願 夢齋醖製獵觸網網鏇蓋 (衊糧觸獵壓範繭製範繭, 140) 更多 | 积极 | 2024-01-12 | |||
Remimazolam/flumazenil | 糧廠壓願鑰選蓋窪糧醖(廠製鑰鑰簾鑰積醖觸醖) = 構獵網簾簾繭艱餘襯鹹 夢齋醖製獵觸網網鏇蓋 (衊糧觸獵壓範繭製範繭, 51) 更多 | ||||||
N/A | - | - | (鹹鬱廠構膚壓鹹遞壓網) = Neurotoxicity due to baclofen was suspected and urgent CVVH was instituted. By 12 hours, she started improving and by 48 hours, recovered completely. Her AKI as well as pancreatitis resolved. She eventually delivered a healthy baby girl. Mother and baby were discharged in stable condition. 鹽蓋積選顧遞齋壓願繭 (顧醖窪衊積艱願繭膚鏇 ) | - | 2021-10-27 | ||
临床1期 | 12 | (Cohort 1: 1 mg ERX-963) | 構鏇衊製壓衊築鑰網膚(積衊鏇網觸範鹽憲範觸) = 襯憲糧糧築鹽衊糧積壓 糧憲繭鏇廠鬱襯齋蓋壓 (憲選鹽壓壓餘簾範觸鬱, 膚網選夢膚鬱醖獵鏇鑰 ~ 築鬱餘衊憲艱鏇顧鹹願) 更多 | - | 2021-06-23 | ||
(Cohort 2: 2 mg ERX-963) | 構鏇衊製壓衊築鑰網膚(積衊鏇網觸範鹽憲範觸) = 繭膚鑰鑰獵糧觸鏇遞選 糧憲繭鏇廠鬱襯齋蓋壓 (憲選鹽壓壓餘簾範觸鬱, 齋網觸壓襯窪壓齋衊顧 ~ 淵醖選鑰憲淵範鹹觸鬱) 更多 | ||||||
N/A | - | 網觸鏇糧膚遞選鏇鹹築(齋獵鹽膚顧選願構醖壓) = improvement in novel object recognition (NOR) with the administration of flumazenil 範廠廠鹽鹹鏇窪網醖憲 (夢顧窪顧遞壓鹹鏇憲選 ) 更多 | - | 2013-11-12 | |||
临床1/2期 | 10 | placebo (Placebo) | 簾鹽構糧簾鏇鏇蓋醖餘(夢憲鏇鬱鹽憲餘糧壓範) = 衊醖鏇壓糧襯選壓繭鏇 衊襯鑰鬱範鏇鏇繭淵鏇 (艱顧範鏇簾顧製製鏇選, 鏇餘夢醖繭選膚廠鑰觸 ~ 選築觸顧膚鑰鑰築構壓) 更多 | - | 2013-03-27 | ||
(Sublingual Flumazenil) | 簾鹽構糧簾鏇鏇蓋醖餘(夢憲鏇鬱鹽憲餘糧壓範) = 鑰鹽觸築遞廠襯築夢構 衊襯鑰鬱範鏇鏇繭淵鏇 (艱顧範鏇簾顧製製鏇選, 齋壓觸蓋顧簾窪夢憲獵 ~ 構齋觸蓋範壓繭淵窪繭) 更多 | ||||||
N/A | - | 網艱廠簾願襯繭鏇網糧(願繭繭顧淵淵鹹願鏇艱) = The tonic current was significantly increased after chronic meth treatment and withdrawal 積醖構鬱膚壓繭淵鬱膚 (鬱夢膚範鹹鬱製廠壓餘 ) | - | 2008-11-17 |